Saturday, August 26, 2006
New Jersey physician Albert Poet was charged with 13 counts of mail fraud and one count of selling a misbranded drug for giving his patients a cheaper, unapproved drug for what his patients thought were Botox treatments. According to a press release (here) issued by the U.S. Attorney's Office:
Poet, a licensed physician, owned and operated Shore Laser Center in Stafford Township and PEAU in Montclair. According to the Indictment, Poet advertised “Botox” treatments in local newspapers and maintained a website to promote his services. According to the Indictment, Poet used a personal credit card to purchase an unapproved form of Botulinium Toxin Type A (the TRI product) from a company named Toxin Research International (TRI), located in Arizona. The company marketed and sold the TRI product from December 2003 until December 2004. Although TRI marketed its product to physicians, the TRI product was sold in injectable vials which were labeled “For Research Purposes Only/Not for Human Use.” According to the Indictment, high doses of Botulinium Toxin Type A can cause Botulism in humans. The Indictment alleges that from December 2003 until January 2005, Poet injected patients with the TRI product without informing them that they were not receiving the brand name drug Botox. The defendant further failed to inform patients that the actual drug used was not approved by the FDA and that the product arrived in vials labeled "For Research Purposes Only/Not for Human Use."
Kinda makes you just want to live with those wrinkles, doesn't it? (ph)